Affiliation:
1. University of California San Francisco, San Francisco, CA, USA
Abstract
Despite widespread availability of human papillomavirus (HPV) vaccines and recommendations for routine use, awareness and uptake of HPV vaccination are not universal. We assessed self-reported history of HPV vaccination in a sample of low-income men and women recruited from the community using respondent-driven sampling as part of the National HIV Behavioral Surveillance (NHBS) survey in San Francisco. Of the 384 respondents, a minority (12.5%) reported they had received the HPV vaccine. In multivariate analysis, independent associations with HPV vaccination history were female sex (adjusted odds ratio [AOR] = 3.76, 95% confidence interval [CI] = [1.73, 8.17]), younger age (AOR = 0.89 per year, 95% CI = [0.86, 0.92]), and education above high school (AOR = 2.84, 95% CI = [1.37, 5.90]). Missed opportunities for HPV vaccination were evident in 84.4% of respondents having visited a health care provider in the last year, including 40.1% tested for a sexually transmitted infection, and entry into higher education programs (33.4%).
Subject
Public Health, Environmental and Occupational Health,Arts and Humanities (miscellaneous)
Reference14 articles.
1. Centers for Disease Control and Prevention. (2022a, July 19). HPV vaccination: Understanding HPV coverage. https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.html
2. Centers for Disease Control and Prevention. (2022b, June 8). STD facts—Human papillomavirus (HPV). https://www.cdc.gov/std/hpv/stdfact-hpv.htm
3. Centers for Disease Control and Prevention. (n.d.a). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm
4. Declining awareness of HPV and HPV vaccine within the general US population